News and updates from IPOX®, including media mentions, interviews, research and press releases.
In a Reuters article covering the successful IPO of Accelerant, IPOX® Research Associate Lukas Muehlbauer provided expert commentary on the surge in insurance listings. He noted that recent market volatility has prompted a "flight to quality," with investors favoring the predictable cash flows and defensive models of insurance companies.
In its coverage of the McGraw Hill IPO, IFR quoted IPOX® VP Kat Liu She commented on the offering, which priced below its expected range, anticipating a "tepid debut" for the company. Liu also noted the firm has "long-term potential" as it works to build momentum.
In a recent article by Reuters, IPOX® Associate Lukas Muehlbauer offered his analysis on the market debut of firearms retailer GrabAGun (PEW). Muehlbauer comments on the company's decision to go public via a SPAC merger, noting, "The company's polarizing brand likely led it to choose a SPAC merger over a traditional IPO, exposing it to the market's skepticism."
In a Reuters article covering McGraw Hill's planned $4.2 billion IPO, IPOX® Vice President Kat Liu provided insight into the current market. She noted that the IPO window "feels more tactical than structural," prompting private equity sponsors to accelerate listing timelines "to get ahead of potential volatility" and secure liquidity while the opportunity is available.
IPOX® Research Associate Dr. Lukas Muehlbauer commented on key trends in European IPOs for Bloomberg, noting the best listings have been growth stories where proceeds are reinvested into the company, rather than deals where private equity owners cash out. Muehlbauer added that companies listing in the Nordic region and recent smaller listings have been the primary beneficiaries.
In a Bloomberg feature on private equity-backed companies returning to the public markets, IPOX® Founder Josef Schuster provided key insights. He explained that these offerings are "usually more efficiently priced than other IPOs, so we don’t expect to see a significant pop initially," despite a wide-open IPO window.
In a new report, Zacks Investment Research highlights two IPOX®-based ETFs (FPX, FPXI) as prime ways to access the recovering IPO market. Citing a sharp rebound in new listings and strong investor sentiment, the analysis points to significant growth opportunities. Our flagship U.S. and International indexes provide the basis for these featured funds.
In a Reuters article on Ambiq Micro's U.S. IPO filing, IPOX® Research Associate Lukas Muehlbauer provided analysis on the company’s plans. He noted the chip designer's customer concentration risk but also highlighted its competitive advantage in the wearables market by targeting the "AI at the edge" niche with its ultra-low-power chips.
In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the significant rights issuance planned by Saudi Arabia's ACWA Power Co. The utility company is set to undertake the Middle East's largest such deal since 2023, aiming to raise $1.9 billion to fund its strategic expansion.